Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival
It is unclear whether invasive intraductal papillary mucinous neoplasm (IPMN) has different clinical and prognostic characteristics, beyond histological factors, when compared to pancreatic ductal adenocarcinoma (PDAC). compare prognostic features of resected PDAC and invasive IPMN A retrospective s...
Gespeichert in:
| Veröffentlicht in: | Digestive and liver disease 2022-06, Vol.54 (6), p.826-833 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 833 |
|---|---|
| container_issue | 6 |
| container_start_page | 826 |
| container_title | Digestive and liver disease |
| container_volume | 54 |
| creator | Gavazzi, Francesca Capretti, Giovanni Giordano, Laura Ridolfi, Cristina Spaggiari, Paola Sollai, Mauro Carrara, Silvia Nappo, Gennaro Bozzarelli, Silvia Zerbi, Alessandro |
| description | It is unclear whether invasive intraductal papillary mucinous neoplasm (IPMN) has different clinical and prognostic characteristics, beyond histological factors, when compared to pancreatic ductal adenocarcinoma (PDAC).
compare prognostic features of resected PDAC and invasive IPMN
A retrospective study of patients resected for PDAC or invasive IPMN realized at Humanitas Cancer Center's Pancreatic Surgery Unit, Milan, Italy, between 2010 and 2016. Data recorded included patient demographics, onset symptoms, preoperative health status, tumor features, histology and surgical characteristics. Overall survival was estimated using Kaplan-Meier and prognostic factors for survival were assessed by multivariate Cox regression.
A total of 332 patients were included (PDAC, n = 289; invasive IPMN, n = 43). Patients with invasive IPMN had better overall survival than PDAC patients (median: 76.6 versus 25.6 months; 5-year OS rate: 65.4% vs. 14.2%; p |
| doi_str_mv | 10.1016/j.dld.2021.06.006 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2548616085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1590865821003224</els_id><sourcerecordid>2548616085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-d67e07344e117b4df66725d6f2b9ade6736c9b12421e40305763f08adc5d11a23</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0Eon88ABvkJZuk107sZGCFCrRIlWDRri2PfY08SuzBdiL1KfrKeDRDl6x8F-d-uscfIe8ZtAyYvN61drItB85akC2AfEXO2TiMTSckf11nsYFmlGI8Ixc576CCUsBbctb1nG2g78_J8y8dTEJdvKF2MUVPVFsM0ehkfIizpjpY6sOqs1-xDiXpE7fXez9NOj3ReTmwS6ZlmWP6RL965zBhKHSf4u8Q8yHdaVNiytTFRO0LEFdMeppoXtLqVz1dkTdOTxnfnd5L8vj928PNXXP_8_bHzZf7xnRclsbKAWHo-h4ZG7a9dVIOXFjp-HZT75dDJ81my3j1xB46EIPsHIzaGmEZ07y7JB-PufXCPwvmomafDVafgNVEcdGPkkkYRUXZETUp5pzQqX3yc_VWDNShB7VTtQd16EGBVLWHuvPhFL9sZ7QvG_8-vgKfjwBWydVjUtl4DAatT2iKstH_J_4vsXKcHQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548616085</pqid></control><display><type>article</type><title>Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Gavazzi, Francesca ; Capretti, Giovanni ; Giordano, Laura ; Ridolfi, Cristina ; Spaggiari, Paola ; Sollai, Mauro ; Carrara, Silvia ; Nappo, Gennaro ; Bozzarelli, Silvia ; Zerbi, Alessandro</creator><creatorcontrib>Gavazzi, Francesca ; Capretti, Giovanni ; Giordano, Laura ; Ridolfi, Cristina ; Spaggiari, Paola ; Sollai, Mauro ; Carrara, Silvia ; Nappo, Gennaro ; Bozzarelli, Silvia ; Zerbi, Alessandro</creatorcontrib><description>It is unclear whether invasive intraductal papillary mucinous neoplasm (IPMN) has different clinical and prognostic characteristics, beyond histological factors, when compared to pancreatic ductal adenocarcinoma (PDAC).
compare prognostic features of resected PDAC and invasive IPMN
A retrospective study of patients resected for PDAC or invasive IPMN realized at Humanitas Cancer Center's Pancreatic Surgery Unit, Milan, Italy, between 2010 and 2016. Data recorded included patient demographics, onset symptoms, preoperative health status, tumor features, histology and surgical characteristics. Overall survival was estimated using Kaplan-Meier and prognostic factors for survival were assessed by multivariate Cox regression.
A total of 332 patients were included (PDAC, n = 289; invasive IPMN, n = 43). Patients with invasive IPMN had better overall survival than PDAC patients (median: 76.6 versus 25.6 months; 5-year OS rate: 65.4% vs. 14.2%; p < 0.001). PDAC histology was associated with a significantly higher risk of death than IPMN (hazard ratio 1.815, 95% CI: 1.02, 3.24; p = 0.044). Survival was also worse with PDAC in early-stage disease (IA-IB-IIA, N0). In multivariate analysis, independent predictors of worse survival included perineural invasion, preoperative ASA physical status ≥3 and pain at diagnosis.
Patients with IPMN had a better prognosis than PDAC patients, regardless of disease stage.</description><identifier>ISSN: 1590-8658</identifier><identifier>EISSN: 1878-3562</identifier><identifier>DOI: 10.1016/j.dld.2021.06.006</identifier><identifier>PMID: 34219044</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adenocarcinoma, Mucinous - pathology ; Adenocarcinoma, Mucinous - surgery ; Carcinoma, Pancreatic Ductal ; Humans ; IPMN ; Pancreatic cancer ; Pancreatic Intraductal Neoplasms - surgery ; Pancreatic Neoplasms ; Pancreatic Neoplasms - pathology ; Prognosis ; Prognostic factors ; Retrospective Studies ; Survival</subject><ispartof>Digestive and liver disease, 2022-06, Vol.54 (6), p.826-833</ispartof><rights>2021 Editrice Gastroenterologica Italiana S.r.l.</rights><rights>Copyright © 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-d67e07344e117b4df66725d6f2b9ade6736c9b12421e40305763f08adc5d11a23</citedby><cites>FETCH-LOGICAL-c326t-d67e07344e117b4df66725d6f2b9ade6736c9b12421e40305763f08adc5d11a23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dld.2021.06.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34219044$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gavazzi, Francesca</creatorcontrib><creatorcontrib>Capretti, Giovanni</creatorcontrib><creatorcontrib>Giordano, Laura</creatorcontrib><creatorcontrib>Ridolfi, Cristina</creatorcontrib><creatorcontrib>Spaggiari, Paola</creatorcontrib><creatorcontrib>Sollai, Mauro</creatorcontrib><creatorcontrib>Carrara, Silvia</creatorcontrib><creatorcontrib>Nappo, Gennaro</creatorcontrib><creatorcontrib>Bozzarelli, Silvia</creatorcontrib><creatorcontrib>Zerbi, Alessandro</creatorcontrib><title>Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival</title><title>Digestive and liver disease</title><addtitle>Dig Liver Dis</addtitle><description>It is unclear whether invasive intraductal papillary mucinous neoplasm (IPMN) has different clinical and prognostic characteristics, beyond histological factors, when compared to pancreatic ductal adenocarcinoma (PDAC).
compare prognostic features of resected PDAC and invasive IPMN
A retrospective study of patients resected for PDAC or invasive IPMN realized at Humanitas Cancer Center's Pancreatic Surgery Unit, Milan, Italy, between 2010 and 2016. Data recorded included patient demographics, onset symptoms, preoperative health status, tumor features, histology and surgical characteristics. Overall survival was estimated using Kaplan-Meier and prognostic factors for survival were assessed by multivariate Cox regression.
A total of 332 patients were included (PDAC, n = 289; invasive IPMN, n = 43). Patients with invasive IPMN had better overall survival than PDAC patients (median: 76.6 versus 25.6 months; 5-year OS rate: 65.4% vs. 14.2%; p < 0.001). PDAC histology was associated with a significantly higher risk of death than IPMN (hazard ratio 1.815, 95% CI: 1.02, 3.24; p = 0.044). Survival was also worse with PDAC in early-stage disease (IA-IB-IIA, N0). In multivariate analysis, independent predictors of worse survival included perineural invasion, preoperative ASA physical status ≥3 and pain at diagnosis.
Patients with IPMN had a better prognosis than PDAC patients, regardless of disease stage.</description><subject>Adenocarcinoma, Mucinous - pathology</subject><subject>Adenocarcinoma, Mucinous - surgery</subject><subject>Carcinoma, Pancreatic Ductal</subject><subject>Humans</subject><subject>IPMN</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Intraductal Neoplasms - surgery</subject><subject>Pancreatic Neoplasms</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Prognosis</subject><subject>Prognostic factors</subject><subject>Retrospective Studies</subject><subject>Survival</subject><issn>1590-8658</issn><issn>1878-3562</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAURi0Eon88ABvkJZuk107sZGCFCrRIlWDRri2PfY08SuzBdiL1KfrKeDRDl6x8F-d-uscfIe8ZtAyYvN61drItB85akC2AfEXO2TiMTSckf11nsYFmlGI8Ixc576CCUsBbctb1nG2g78_J8y8dTEJdvKF2MUVPVFsM0ehkfIizpjpY6sOqs1-xDiXpE7fXez9NOj3ReTmwS6ZlmWP6RL965zBhKHSf4u8Q8yHdaVNiytTFRO0LEFdMeppoXtLqVz1dkTdOTxnfnd5L8vj928PNXXP_8_bHzZf7xnRclsbKAWHo-h4ZG7a9dVIOXFjp-HZT75dDJ81my3j1xB46EIPsHIzaGmEZ07y7JB-PufXCPwvmomafDVafgNVEcdGPkkkYRUXZETUp5pzQqX3yc_VWDNShB7VTtQd16EGBVLWHuvPhFL9sZ7QvG_8-vgKfjwBWydVjUtl4DAatT2iKstH_J_4vsXKcHQ</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Gavazzi, Francesca</creator><creator>Capretti, Giovanni</creator><creator>Giordano, Laura</creator><creator>Ridolfi, Cristina</creator><creator>Spaggiari, Paola</creator><creator>Sollai, Mauro</creator><creator>Carrara, Silvia</creator><creator>Nappo, Gennaro</creator><creator>Bozzarelli, Silvia</creator><creator>Zerbi, Alessandro</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202206</creationdate><title>Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival</title><author>Gavazzi, Francesca ; Capretti, Giovanni ; Giordano, Laura ; Ridolfi, Cristina ; Spaggiari, Paola ; Sollai, Mauro ; Carrara, Silvia ; Nappo, Gennaro ; Bozzarelli, Silvia ; Zerbi, Alessandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-d67e07344e117b4df66725d6f2b9ade6736c9b12421e40305763f08adc5d11a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adenocarcinoma, Mucinous - pathology</topic><topic>Adenocarcinoma, Mucinous - surgery</topic><topic>Carcinoma, Pancreatic Ductal</topic><topic>Humans</topic><topic>IPMN</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Intraductal Neoplasms - surgery</topic><topic>Pancreatic Neoplasms</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Prognosis</topic><topic>Prognostic factors</topic><topic>Retrospective Studies</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gavazzi, Francesca</creatorcontrib><creatorcontrib>Capretti, Giovanni</creatorcontrib><creatorcontrib>Giordano, Laura</creatorcontrib><creatorcontrib>Ridolfi, Cristina</creatorcontrib><creatorcontrib>Spaggiari, Paola</creatorcontrib><creatorcontrib>Sollai, Mauro</creatorcontrib><creatorcontrib>Carrara, Silvia</creatorcontrib><creatorcontrib>Nappo, Gennaro</creatorcontrib><creatorcontrib>Bozzarelli, Silvia</creatorcontrib><creatorcontrib>Zerbi, Alessandro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive and liver disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gavazzi, Francesca</au><au>Capretti, Giovanni</au><au>Giordano, Laura</au><au>Ridolfi, Cristina</au><au>Spaggiari, Paola</au><au>Sollai, Mauro</au><au>Carrara, Silvia</au><au>Nappo, Gennaro</au><au>Bozzarelli, Silvia</au><au>Zerbi, Alessandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival</atitle><jtitle>Digestive and liver disease</jtitle><addtitle>Dig Liver Dis</addtitle><date>2022-06</date><risdate>2022</risdate><volume>54</volume><issue>6</issue><spage>826</spage><epage>833</epage><pages>826-833</pages><issn>1590-8658</issn><eissn>1878-3562</eissn><abstract>It is unclear whether invasive intraductal papillary mucinous neoplasm (IPMN) has different clinical and prognostic characteristics, beyond histological factors, when compared to pancreatic ductal adenocarcinoma (PDAC).
compare prognostic features of resected PDAC and invasive IPMN
A retrospective study of patients resected for PDAC or invasive IPMN realized at Humanitas Cancer Center's Pancreatic Surgery Unit, Milan, Italy, between 2010 and 2016. Data recorded included patient demographics, onset symptoms, preoperative health status, tumor features, histology and surgical characteristics. Overall survival was estimated using Kaplan-Meier and prognostic factors for survival were assessed by multivariate Cox regression.
A total of 332 patients were included (PDAC, n = 289; invasive IPMN, n = 43). Patients with invasive IPMN had better overall survival than PDAC patients (median: 76.6 versus 25.6 months; 5-year OS rate: 65.4% vs. 14.2%; p < 0.001). PDAC histology was associated with a significantly higher risk of death than IPMN (hazard ratio 1.815, 95% CI: 1.02, 3.24; p = 0.044). Survival was also worse with PDAC in early-stage disease (IA-IB-IIA, N0). In multivariate analysis, independent predictors of worse survival included perineural invasion, preoperative ASA physical status ≥3 and pain at diagnosis.
Patients with IPMN had a better prognosis than PDAC patients, regardless of disease stage.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>34219044</pmid><doi>10.1016/j.dld.2021.06.006</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1590-8658 |
| ispartof | Digestive and liver disease, 2022-06, Vol.54 (6), p.826-833 |
| issn | 1590-8658 1878-3562 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2548616085 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adenocarcinoma, Mucinous - pathology Adenocarcinoma, Mucinous - surgery Carcinoma, Pancreatic Ductal Humans IPMN Pancreatic cancer Pancreatic Intraductal Neoplasms - surgery Pancreatic Neoplasms Pancreatic Neoplasms - pathology Prognosis Prognostic factors Retrospective Studies Survival |
| title | Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A03%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pancreatic%20ductal%20adenocarcinoma%20and%20invasive%20intraductal%20papillary%20mucinous%20tumor:%20Different%20prognostic%20factors%20for%20different%20overall%20survival&rft.jtitle=Digestive%20and%20liver%20disease&rft.au=Gavazzi,%20Francesca&rft.date=2022-06&rft.volume=54&rft.issue=6&rft.spage=826&rft.epage=833&rft.pages=826-833&rft.issn=1590-8658&rft.eissn=1878-3562&rft_id=info:doi/10.1016/j.dld.2021.06.006&rft_dat=%3Cproquest_cross%3E2548616085%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2548616085&rft_id=info:pmid/34219044&rft_els_id=S1590865821003224&rfr_iscdi=true |